<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-11-02" modified="2020-10-07" version="224">
<accession>Q14643</accession>
<accession>E7EPX7</accession>
<accession>E9PDE9</accession>
<accession>Q14660</accession>
<accession>Q99897</accession>
<name>ITPR1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Inositol 1,4,5-trisphosphate receptor type 1</fullName>
</recommendedName>
<alternativeName>
<fullName>IP3 receptor isoform 1</fullName>
<shortName>IP3R 1</shortName>
<shortName>InsP3R1</shortName>
</alternativeName>
<alternativeName>
<fullName>Type 1 inositol 1,4,5-trisphosphate receptor</fullName>
<shortName>Type 1 InsP3 receptor</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">ITPR1</name>
<name type="synonym">INSP3R1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1994" name="Biochem. J." volume="302" first="781" last="790">
<title>Human inositol 1,4,5-trisphosphate type-1 receptor, InsP3R1: structure, function, regulation of expression and chromosomal localization.</title>
<authorList>
<person name="Yamada N."/>
<person name="Makino Y."/>
<person name="Clark R.A."/>
<person name="Pearson D.W."/>
<person name="Mattei M.-G."/>
<person name="Guenet J.-L."/>
<person name="Ohama E."/>
<person name="Fujino I."/>
<person name="Miyawaki A."/>
<person name="Furuichi T."/>
<person name="Mikoshiba K."/>
</authorList>
<dbReference type="PubMed" id="7945203"/>
<dbReference type="DOI" id="10.1042/bj3020781"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4)</scope>
<source>
<tissue>Myeloid</tissue>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="2833" last="2840">
<title>The human type 1 inositol 1,4,5-trisphosphate receptor from T lymphocytes. Structure, localization, and tyrosine phosphorylation.</title>
<authorList>
<person name="Harnick D.J."/>
<person name="Jayaraman T."/>
<person name="Ma Y."/>
<person name="Mulieri P."/>
<person name="Go L.O."/>
<person name="Marks A.R."/>
</authorList>
<dbReference type="PubMed" id="7852357"/>
<dbReference type="DOI" id="10.1074/jbc.270.6.2833"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
<scope>PHOSPHORYLATION</scope>
<source>
<tissue>T-cell</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2004-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Marks A."/>
</authorList>
</citation>
<scope>SEQUENCE REVISION TO 431; 1012-1017; 1460; 1823; 2324; 2330; 2334; 2337; 2346; 2358; 2361; 2372; 2396; 2418; 2426; 2434 AND 2741</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1995" name="Brain Res. Mol. Brain Res." volume="32" first="291" last="296">
<title>Molecular cloning of a cDNA for the human inositol 1,4,5-trisphosphate receptor type 1, and the identification of a third alternatively spliced variant.</title>
<authorList>
<person name="Nucifora F.C. Jr."/>
<person name="Li S.-H."/>
<person name="Danoff S."/>
<person name="Ullrich A."/>
<person name="Ross C.A."/>
</authorList>
<dbReference type="PubMed" id="7500840"/>
<dbReference type="DOI" id="10.1016/0169-328x(95)00089-b"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>ALTERNATIVE SPLICING</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2006" name="Nature" volume="440" first="1194" last="1198">
<title>The DNA sequence, annotation and analysis of human chromosome 3.</title>
<authorList>
<person name="Muzny D.M."/>
<person name="Scherer S.E."/>
<person name="Kaul R."/>
<person name="Wang J."/>
<person name="Yu J."/>
<person name="Sudbrak R."/>
<person name="Buhay C.J."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Ding Y."/>
<person name="Dugan-Rocha S."/>
<person name="Gill R."/>
<person name="Gunaratne P."/>
<person name="Harris R.A."/>
<person name="Hawes A.C."/>
<person name="Hernandez J."/>
<person name="Hodgson A.V."/>
<person name="Hume J."/>
<person name="Jackson A."/>
<person name="Khan Z.M."/>
<person name="Kovar-Smith C."/>
<person name="Lewis L.R."/>
<person name="Lozado R.J."/>
<person name="Metzker M.L."/>
<person name="Milosavljevic A."/>
<person name="Miner G.R."/>
<person name="Morgan M.B."/>
<person name="Nazareth L.V."/>
<person name="Scott G."/>
<person name="Sodergren E."/>
<person name="Song X.-Z."/>
<person name="Steffen D."/>
<person name="Wei S."/>
<person name="Wheeler D.A."/>
<person name="Wright M.W."/>
<person name="Worley K.C."/>
<person name="Yuan Y."/>
<person name="Zhang Z."/>
<person name="Adams C.Q."/>
<person name="Ansari-Lari M.A."/>
<person name="Ayele M."/>
<person name="Brown M.J."/>
<person name="Chen G."/>
<person name="Chen Z."/>
<person name="Clendenning J."/>
<person name="Clerc-Blankenburg K.P."/>
<person name="Chen R."/>
<person name="Chen Z."/>
<person name="Davis C."/>
<person name="Delgado O."/>
<person name="Dinh H.H."/>
<person name="Dong W."/>
<person name="Draper H."/>
<person name="Ernst S."/>
<person name="Fu G."/>
<person name="Gonzalez-Garay M.L."/>
<person name="Garcia D.K."/>
<person name="Gillett W."/>
<person name="Gu J."/>
<person name="Hao B."/>
<person name="Haugen E."/>
<person name="Havlak P."/>
<person name="He X."/>
<person name="Hennig S."/>
<person name="Hu S."/>
<person name="Huang W."/>
<person name="Jackson L.R."/>
<person name="Jacob L.S."/>
<person name="Kelly S.H."/>
<person name="Kube M."/>
<person name="Levy R."/>
<person name="Li Z."/>
<person name="Liu B."/>
<person name="Liu J."/>
<person name="Liu W."/>
<person name="Lu J."/>
<person name="Maheshwari M."/>
<person name="Nguyen B.-V."/>
<person name="Okwuonu G.O."/>
<person name="Palmeiri A."/>
<person name="Pasternak S."/>
<person name="Perez L.M."/>
<person name="Phelps K.A."/>
<person name="Plopper F.J."/>
<person name="Qiang B."/>
<person name="Raymond C."/>
<person name="Rodriguez R."/>
<person name="Saenphimmachak C."/>
<person name="Santibanez J."/>
<person name="Shen H."/>
<person name="Shen Y."/>
<person name="Subramanian S."/>
<person name="Tabor P.E."/>
<person name="Verduzco D."/>
<person name="Waldron L."/>
<person name="Wang J."/>
<person name="Wang J."/>
<person name="Wang Q."/>
<person name="Williams G.A."/>
<person name="Wong G.K.-S."/>
<person name="Yao Z."/>
<person name="Zhang J."/>
<person name="Zhang X."/>
<person name="Zhao G."/>
<person name="Zhou J."/>
<person name="Zhou Y."/>
<person name="Nelson D."/>
<person name="Lehrach H."/>
<person name="Reinhardt R."/>
<person name="Naylor S.L."/>
<person name="Yang H."/>
<person name="Olson M."/>
<person name="Weinstock G."/>
<person name="Gibbs R.A."/>
</authorList>
<dbReference type="PubMed" id="16641997"/>
<dbReference type="DOI" id="10.1038/nature04728"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1996" name="Int. J. Radiat. Biol." volume="69" first="539" last="546">
<title>Induction of inositol 1,4,5 trisphosphate receptor genes by ionizing radiation.</title>
<authorList>
<person name="Yan J."/>
<person name="Khanna K.K."/>
<person name="Lavin M.F."/>
</authorList>
<dbReference type="PubMed" id="8648241"/>
<dbReference type="DOI" id="10.1080/095530096145544"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1548-1723 (ISOFORMS 3 AND 4)</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="7711" last="7716">
<title>Identification of a family of calcium sensors as protein ligands of inositol trisphosphate receptor Ca(2+) release channels.</title>
<authorList>
<person name="Yang J."/>
<person name="McBride S."/>
<person name="Mak D.-O.D."/>
<person name="Vardi N."/>
<person name="Palczewski K."/>
<person name="Haeseleer F."/>
<person name="Foskett J.K."/>
</authorList>
<dbReference type="PubMed" id="12032348"/>
<dbReference type="DOI" id="10.1073/pnas.102006299"/>
</citation>
<scope>INTERACTION WITH CABP1</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="EMBO J." volume="23" first="312" last="321">
<title>Regulation of InsP3 receptor activity by neuronal Ca2+-binding proteins.</title>
<authorList>
<person name="Kasri N.N."/>
<person name="Holmes A.M."/>
<person name="Bultynck G."/>
<person name="Parys J.B."/>
<person name="Bootman M.D."/>
<person name="Rietdorf K."/>
<person name="Missiaen L."/>
<person name="McDonald F."/>
<person name="De Smedt H."/>
<person name="Conway S.J."/>
<person name="Holmes A.B."/>
<person name="Berridge M.J."/>
<person name="Roderick H.L."/>
</authorList>
<dbReference type="PubMed" id="14685260"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600037"/>
</citation>
<scope>INTERACTION WITH CABP1</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2005" name="Cell" volume="120" first="85" last="98">
<title>Subtype-specific and ER lumenal environment-dependent regulation of inositol 1,4,5-trisphosphate receptor type 1 by ERp44.</title>
<authorList>
<person name="Higo T."/>
<person name="Hattori M."/>
<person name="Nakamura T."/>
<person name="Natsume T."/>
<person name="Michikawa T."/>
<person name="Mikoshiba K."/>
</authorList>
<dbReference type="PubMed" id="15652484"/>
<dbReference type="DOI" id="10.1016/j.cell.2004.11.048"/>
</citation>
<scope>INTERACTION WITH ERP44</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1598</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2006" name="Mol. Cell" volume="22" first="795" last="806">
<title>IRBIT suppresses IP3 receptor activity by competing with IP3 for the common binding site on the IP3 receptor.</title>
<authorList>
<person name="Ando H."/>
<person name="Mizutani A."/>
<person name="Kiefer H."/>
<person name="Tsuzurugi D."/>
<person name="Michikawa T."/>
<person name="Mikoshiba K."/>
</authorList>
<dbReference type="PubMed" id="16793548"/>
<dbReference type="DOI" id="10.1016/j.molcel.2006.05.017"/>
</citation>
<scope>INTERACTION WITH AHCYL1</scope>
<scope>MUTAGENESIS OF ARG-241; LYS-249; ARG-265; THR-267; ARG-269; ARG-504; ARG-506; LYS-508; ARG-511; TYR-567; ARG-568 AND LYS-569</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2007" name="Blood" volume="109" first="552" last="559">
<title>IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation.</title>
<authorList>
<person name="Antl M."/>
<person name="von Bruehl M.-L."/>
<person name="Eiglsperger C."/>
<person name="Werner M."/>
<person name="Konrad I."/>
<person name="Kocher T."/>
<person name="Wilm M."/>
<person name="Hofmann F."/>
<person name="Massberg S."/>
<person name="Schlossmann J."/>
</authorList>
<dbReference type="PubMed" id="16990611"/>
<dbReference type="DOI" id="10.1182/blood-2005-10-026294"/>
</citation>
<scope>INTERACTION WITH IRAG1</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2007" name="PLoS Genet." volume="3" first="1076" last="1082">
<title>Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia 15 in humans.</title>
<authorList>
<person name="van de Leemput J."/>
<person name="Chandran J."/>
<person name="Knight M.A."/>
<person name="Holtzclaw L.A."/>
<person name="Scholz S."/>
<person name="Cookson M.R."/>
<person name="Houlden H."/>
<person name="Gwinn-Hardy K."/>
<person name="Fung H.-C."/>
<person name="Lin X."/>
<person name="Hernandez D."/>
<person name="Simon-Sanchez J."/>
<person name="Wood N.W."/>
<person name="Giunti P."/>
<person name="Rafferty I."/>
<person name="Hardy J."/>
<person name="Storey E."/>
<person name="Gardner R.J.M."/>
<person name="Forrest S.M."/>
<person name="Fisher E.M.C."/>
<person name="Russell J.T."/>
<person name="Cai H."/>
<person name="Singleton A.B."/>
</authorList>
<dbReference type="PubMed" id="17590087"/>
<dbReference type="DOI" id="10.1371/journal.pgen.0030108"/>
</citation>
<scope>INVOLVEMENT IN SCA15</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1598 AND SER-1764</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="J. Neurochem." volume="109" first="539" last="550">
<title>An IRBIT homologue lacks binding activity to inositol 1,4,5-trisphosphate receptor due to the unique N-terminal appendage.</title>
<authorList>
<person name="Ando H."/>
<person name="Mizutani A."/>
<person name="Mikoshiba K."/>
</authorList>
<dbReference type="PubMed" id="19220705"/>
<dbReference type="DOI" id="10.1111/j.1471-4159.2009.05979.x"/>
</citation>
<scope>INTERACTION WITH AHCYL1 AND AHCYL2</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
<title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
<authorList>
<person name="Chen R."/>
<person name="Jiang X."/>
<person name="Sun D."/>
<person name="Han G."/>
<person name="Wang F."/>
<person name="Ye M."/>
<person name="Wang L."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="19159218"/>
<dbReference type="DOI" id="10.1021/pr8008012"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-2512</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1598</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2012" name="FEBS Open Bio" volume="2" first="255" last="259">
<title>Tespa1 is a novel inositol 1,4,5-trisphosphate receptor binding protein in T and B lymphocytes.</title>
<authorList>
<person name="Matsuzaki H."/>
<person name="Fujimoto T."/>
<person name="Ota T."/>
<person name="Ogawa M."/>
<person name="Tsunoda T."/>
<person name="Doi K."/>
<person name="Hamabashiri M."/>
<person name="Tanaka M."/>
<person name="Shirasawa S."/>
</authorList>
<dbReference type="PubMed" id="23650607"/>
<dbReference type="DOI" id="10.1016/j.fob.2012.08.005"/>
</citation>
<scope>INTERACTION WITH TESPA1</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2013" name="J. Biol. Chem." volume="288" first="25340" last="25349">
<title>The Bcl-2 protein family member Bok binds to the coupling domain of inositol 1,4,5-trisphosphate receptors and protects them from proteolytic cleavage.</title>
<authorList>
<person name="Schulman J.J."/>
<person name="Wright F.A."/>
<person name="Kaufmann T."/>
<person name="Wojcikiewicz R.J."/>
</authorList>
<dbReference type="PubMed" id="23884412"/>
<dbReference type="DOI" id="10.1074/jbc.m113.496570"/>
</citation>
<scope>INTERACTION WITH BOK</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1598 AND SER-1764</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1598</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2016" name="Elife" volume="5" first="e19896" last="e19896">
<title>IRBIT controls apoptosis by interacting with the Bcl-2 homolog, Bcl2l10, and by promoting ER-mitochondria contact.</title>
<authorList>
<person name="Bonneau B."/>
<person name="Ando H."/>
<person name="Kawaai K."/>
<person name="Hirose M."/>
<person name="Takahashi-Iwanaga H."/>
<person name="Mikoshiba K."/>
</authorList>
<dbReference type="PubMed" id="27995898"/>
<dbReference type="DOI" id="10.7554/elife.19896"/>
</citation>
<scope>INTERACTION WITH AHCYL1 AND BCL2L10</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2008" name="Neurology" volume="71" first="547" last="551">
<title>Total deletion and a missense mutation of ITPR1 in Japanese SCA15 families.</title>
<authorList>
<person name="Hara K."/>
<person name="Shiga A."/>
<person name="Nozaki H."/>
<person name="Mitsui J."/>
<person name="Takahashi Y."/>
<person name="Ishiguro H."/>
<person name="Yomono H."/>
<person name="Kurisaki H."/>
<person name="Goto J."/>
<person name="Ikeuchi T."/>
<person name="Tsuji S."/>
<person name="Nishizawa M."/>
<person name="Onodera O."/>
</authorList>
<dbReference type="PubMed" id="18579805"/>
<dbReference type="DOI" id="10.1212/01.wnl.0000311277.71046.a0"/>
</citation>
<scope>VARIANT SCA15 LEU-1083</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2012" name="Orphanet J. Rare Dis." volume="7" first="67" last="67">
<title>Missense mutations in ITPR1 cause autosomal dominant congenital nonprogressive spinocerebellar ataxia.</title>
<authorList>
<person name="Huang L."/>
<person name="Chardon J.W."/>
<person name="Carter M.T."/>
<person name="Friend K.L."/>
<person name="Dudding T.E."/>
<person name="Schwartzentruber J."/>
<person name="Zou R."/>
<person name="Schofield P.W."/>
<person name="Douglas S."/>
<person name="Bulman D.E."/>
<person name="Boycott K.M."/>
</authorList>
<dbReference type="PubMed" id="22986007"/>
<dbReference type="DOI" id="10.1186/1750-1172-7-67"/>
</citation>
<scope>VARIANTS SCA29 ASP-602 AND MET-1562</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2016" name="Cerebellum Ataxias" volume="3" first="2" last="2">
<title>ITPR1 gene p.Val1553Met mutation in Russian family with mild Spinocerebellar ataxia.</title>
<authorList>
<person name="Shadrina M.I."/>
<person name="Shulskaya M.V."/>
<person name="Klyushnikov S.A."/>
<person name="Nikopensius T."/>
<person name="Nelis M."/>
<person name="Kivistik P.A."/>
<person name="Komar A.A."/>
<person name="Limborska S.A."/>
<person name="Illarioshkin S.N."/>
<person name="Slominsky P.A."/>
</authorList>
<dbReference type="PubMed" id="26770814"/>
<dbReference type="DOI" id="10.1186/s40673-016-0040-8"/>
</citation>
<scope>VARIANT SCA29 MET-1562</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2016" name="Am. J. Hum. Genet." volume="98" first="971" last="980">
<title>Recessive and dominant de novo ITPR1 mutations cause Gillespie syndrome.</title>
<authorList>
<person name="Gerber S."/>
<person name="Alzayady K.J."/>
<person name="Burglen L."/>
<person name="Bremond-Gignac D."/>
<person name="Marchesin V."/>
<person name="Roche O."/>
<person name="Rio M."/>
<person name="Funalot B."/>
<person name="Calmon R."/>
<person name="Durr A."/>
<person name="Gil-da-Silva-Lopes V.L."/>
<person name="Ribeiro Bittar M.F."/>
<person name="Orssaud C."/>
<person name="Heron B."/>
<person name="Ayoub E."/>
<person name="Berquin P."/>
<person name="Bahi-Buisson N."/>
<person name="Bole C."/>
<person name="Masson C."/>
<person name="Munnich A."/>
<person name="Simons M."/>
<person name="Delous M."/>
<person name="Dollfus H."/>
<person name="Boddaert N."/>
<person name="Lyonnet S."/>
<person name="Kaplan J."/>
<person name="Calvas P."/>
<person name="Yule D.I."/>
<person name="Rozet J.M."/>
<person name="Fares Taie L."/>
</authorList>
<dbReference type="PubMed" id="27108797"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2016.03.004"/>
</citation>
<scope>INVOLVEMENT IN GLSP</scope>
<scope>VARIANTS GLSP LEU-2601 AND LYS-2611 DEL</scope>
<scope>CHARACTERIZATION OF VARIANT GLSP LYS-2611 DEL</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2016" name="Am. J. Hum. Genet." volume="98" first="981" last="992">
<title>A restricted repertoire of de novo mutations in ITPR1 cause Gillespie syndrome with evidence for dominant-negative effect.</title>
<authorList>
<consortium name="DDD Study"/>
<person name="McEntagart M."/>
<person name="Williamson K.A."/>
<person name="Rainger J.K."/>
<person name="Wheeler A."/>
<person name="Seawright A."/>
<person name="De Baere E."/>
<person name="Verdin H."/>
<person name="Bergendahl L.T."/>
<person name="Quigley A."/>
<person name="Rainger J."/>
<person name="Dixit A."/>
<person name="Sarkar A."/>
<person name="Lopez Laso E."/>
<person name="Sanchez-Carpintero R."/>
<person name="Barrio J."/>
<person name="Bitoun P."/>
<person name="Prescott T."/>
<person name="Riise R."/>
<person name="McKee S."/>
<person name="Cook J."/>
<person name="McKie L."/>
<person name="Ceulemans B."/>
<person name="Meire F."/>
<person name="Temple I.K."/>
<person name="Prieur F."/>
<person name="Williams J."/>
<person name="Clouston P."/>
<person name="Nemeth A.H."/>
<person name="Banka S."/>
<person name="Bengani H."/>
<person name="Handley M."/>
<person name="Freyer E."/>
<person name="Ross A."/>
<person name="van Heyningen V."/>
<person name="Marsh J.A."/>
<person name="Elmslie F."/>
<person name="FitzPatrick D.R."/>
</authorList>
<dbReference type="PubMed" id="27108798"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2016.03.018"/>
</citation>
<scope>INVOLVEMENT IN GLSP</scope>
<scope>VARIANTS GLSP GLN-2109; ARG-2554 AND LYS-2611 DEL</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2018" name="Cell" volume="175" first="239" last="253">
<title>Mutations in disordered regions can cause disease by creating dileucine motifs.</title>
<authorList>
<person name="Meyer K."/>
<person name="Kirchner M."/>
<person name="Uyar B."/>
<person name="Cheng J.Y."/>
<person name="Russo G."/>
<person name="Hernandez-Miranda L.R."/>
<person name="Szymborska A."/>
<person name="Zauber H."/>
<person name="Rudolph I.M."/>
<person name="Willnow T.E."/>
<person name="Akalin A."/>
<person name="Haucke V."/>
<person name="Gerhardt H."/>
<person name="Birchmeier C."/>
<person name="Kuehn R."/>
<person name="Krauss M."/>
<person name="Diecke S."/>
<person name="Pascual J.M."/>
<person name="Selbach M."/>
</authorList>
<dbReference type="PubMed" id="30197081"/>
<dbReference type="DOI" id="10.1016/j.cell.2018.08.019"/>
</citation>
<scope>MUTAGENESIS OF PRO-1059</scope>
</reference>
<comment type="function">
<text evidence="7 25">Intracellular channel that mediates calcium release from the endoplasmic reticulum following stimulation by inositol 1,4,5-trisphosphate (PubMed:27108797). Involved in the regulation of epithelial secretion of electrolytes and fluid through the interaction with AHCYL1 (By similarity). Plays a role in ER stress-induced apoptosis. Cytoplasmic calcium released from the ER triggers apoptosis by the activation of CaM kinase II, eventually leading to the activation of downstream apoptosis pathways (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="12 13 14 15 16 20 22 23 27">Homotetramer. Interacts with TRPC4. The PPXXF motif binds HOM1, HOM2 and HOM3. Interacts with RYR1, RYR2, ITPR1, SHANK1 and SHANK3. Interacts with ERP44 in a pH-, redox state- and calcium-dependent manner which results in the inhibition the calcium channel activity. The strength of this interaction inversely correlates with calcium concentration. Part of cGMP kinase signaling complex at least composed of ACTA2/alpha-actin, CNN1/calponin H1, PLN/phospholamban, PRKG1 and ITPR1. Interacts with IRAG1 and CABP1 (via N-terminus). Interacts with TESPA1. Interacts (when not phosphorylated) with AHCYL1 (when phosphorylated); the interaction suppresses inositol 1,4,5-trisphosphate binding to ITPR1 and is increased in the presence of BCL2L10 (PubMed:16793548, PubMed:27995898). Interacts with AHCYL2 (with lower affinity than with AHCYL1) (PubMed:19220705). Interacts with BCL2L10; the interaction is increased in the presence of AHCLY1 (PubMed:27995898). Interacts with BOK (via BH4 domain); protects ITPR1 from proteolysis by CASP3 during apoptosis (PubMed:23884412).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-465548">
<id>Q14643</id>
</interactant>
<interactant intactId="EBI-2371423">
<id>O43865</id>
<label>AHCYL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-465548">
<id>Q14643</id>
</interactant>
<interactant intactId="EBI-296087">
<id>P31749</id>
<label>AKT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-465548">
<id>Q14643</id>
</interactant>
<interactant intactId="EBI-2126349">
<id>Q9HD36</id>
<label>BCL2L10</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-465548">
<id>Q14643</id>
</interactant>
<interactant intactId="EBI-354158">
<id>P21796</id>
<label>VDAC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="35">Endoplasmic reticulum membrane</location>
<topology evidence="10">Multi-pass membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Cytoplasmic vesicle</location>
<location evidence="9">Secretory vesicle membrane</location>
<topology evidence="10">Multi-pass membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="26">Cytoplasm</location>
<location evidence="26">Perinuclear region</location>
</subcellularLocation>
<text evidence="9">Endoplasmic reticulum and secretory granules (By similarity).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q14643-1</id>
<name>1</name>
<name>SISIIISIIAC</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q14643-2</id>
<name>2</name>
<name>SI-SIIISIIAC</name>
<sequence type="described" ref="VSP_002687"/>
</isoform>
<isoform>
<id>Q14643-3</id>
<name>3</name>
<name>SISIII-SII</name>
<sequence type="described" ref="VSP_002688 VSP_002689 VSP_002690"/>
</isoform>
<isoform>
<id>Q14643-4</id>
<name>4</name>
<name>SI-SIII-SII</name>
<sequence type="described" ref="VSP_002687 VSP_002688 VSP_002689 VSP_002690"/>
</isoform>
<isoform>
<id>Q14643-5</id>
<name>5</name>
<name>SI-SIII-SIIAC</name>
<sequence type="described" ref="VSP_002687 VSP_002688"/>
</isoform>
<isoform>
<id>Q14643-6</id>
<name>6</name>
<name>SISIIISIIA</name>
<sequence type="described" ref="VSP_002690"/>
</isoform>
<isoform>
<id>Q14643-7</id>
<name>7</name>
<name>SI-SIII-SIIA</name>
<sequence type="described" ref="VSP_002687 VSP_002690"/>
</isoform>
<isoform>
<id>Q14643-8</id>
<name>8</name>
<name>SI-SIII-SIIA</name>
<sequence type="described" ref="VSP_002687 VSP_002688 VSP_002690"/>
</isoform>
<text>There is a combination of three alternatively spliced domains at site SI, SIII and site SII (A and C). Experimental confirmation may be lacking for some isoforms.</text>
</comment>
<comment type="tissue specificity">
<text>Widely expressed.</text>
</comment>
<comment type="domain">
<text>The receptor contains a calcium channel in its C-terminal extremity. Its large N-terminal cytoplasmic region has the ligand-binding site in the N-terminus and modulatory sites in the middle portion immediately upstream of the channel region.</text>
</comment>
<comment type="PTM">
<text evidence="29">Phosphorylated on tyrosine residues.</text>
</comment>
<comment type="PTM">
<text evidence="8">Ubiquitination at multiple lysines targets ITPR1 for proteasomal degradation. Approximately 40% of the ITPR1-associated ubiquitin is monoubiquitin, and polyubiquitins are both 'Lys-48'- and 'Lys-63'-linked (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="7">Phosphorylated by cAMP kinase (PKA). Phosphorylation prevents the ligand-induced opening of the calcium channels. Phosphorylation by PKA increases the interaction with inositol 1,4,5-trisphosphate and decreases the interaction with AHCYL1.</text>
</comment>
<comment type="PTM">
<text evidence="7">Palmitoylated by ZDHHC6 in immune cells, leading to regulate ITPR1 stability and function.</text>
</comment>
<comment type="disease" evidence="17 18">
<disease id="DI-01078">
<name>Spinocerebellar ataxia 15</name>
<acronym>SCA15</acronym>
<description>Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA15 is an autosomal dominant cerebellar ataxia (ADCA). It is very slow progressing form with a wide range of onset, ranging from childhood to adult. Most patients remain ambulatory.</description>
<dbReference type="MIM" id="606658"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="21 24">
<disease id="DI-03660">
<name>Spinocerebellar ataxia 29</name>
<acronym>SCA29</acronym>
<description>An autosomal dominant, congenital spinocerebellar ataxia characterized by early motor delay, hypotonia and mild cognitive delay. Affected individuals develop a very slowly progressive or non-progressive gait and limb ataxia associated with cerebellar atrophy on brain imaging. Additional variable features include nystagmus, dysarthria, and tremor.</description>
<dbReference type="MIM" id="117360"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="25 26">
<disease id="DI-01661">
<name>Gillespie syndrome</name>
<acronym>GLSP</acronym>
<description>A rare disease characterized by bilateral iris hypoplasia, congenital hypotonia, non-progressive ataxia, progressive cerebellar atrophy, and mental retardation.</description>
<dbReference type="MIM" id="206700"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>Calcium appears to inhibit ligand binding to the receptor, most probably by interacting with a distinct calcium-binding protein which then inhibits the receptor.</text>
</comment>
<comment type="similarity">
<text evidence="34">Belongs to the InsP3 receptor family.</text>
</comment>
<comment type="caution">
<text evidence="34">Alternative splice sites (AA 1053-1054) represent a non-canonical GA-AG donor-acceptor pair, but are well-supported by all available human transcripts, and by homologous transcripts in mouse, rat and cow.</text>
</comment>
<dbReference type="EMBL" id="D26070">
<property type="protein sequence ID" value="BAA05065.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L38019">
<property type="protein sequence ID" value="AAB04947.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U23850">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC018816">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC024168">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC069248">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC090944">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S82269">
<property type="protein sequence ID" value="AAD14386.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS46740.2">
<molecule id="Q14643-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54550.1">
<molecule id="Q14643-4"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54551.1">
<molecule id="Q14643-2"/>
</dbReference>
<dbReference type="PIR" id="A55713">
<property type="entry name" value="A55713"/>
</dbReference>
<dbReference type="PIR" id="S54974">
<property type="entry name" value="S54974"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001093422.2">
<molecule id="Q14643-3"/>
<property type="nucleotide sequence ID" value="NM_001099952.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001161744.1">
<molecule id="Q14643-2"/>
<property type="nucleotide sequence ID" value="NM_001168272.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002213.5">
<molecule id="Q14643-4"/>
<property type="nucleotide sequence ID" value="NM_002222.5"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011531985.1">
<property type="nucleotide sequence ID" value="XM_011533683.2"/>
</dbReference>
<dbReference type="SMR" id="Q14643"/>
<dbReference type="BioGRID" id="109913">
<property type="interactions" value="61"/>
</dbReference>
<dbReference type="CORUM" id="Q14643"/>
<dbReference type="DIP" id="DIP-29714N"/>
<dbReference type="ELM" id="Q14643"/>
<dbReference type="IntAct" id="Q14643">
<property type="interactions" value="36"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000306253"/>
<dbReference type="BindingDB" id="Q14643"/>
<dbReference type="ChEMBL" id="CHEMBL4046"/>
<dbReference type="DrugBank" id="DB03401">
<property type="generic name" value="1D-myo-inositol 1,4,5-trisphosphate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00201">
<property type="generic name" value="Caffeine"/>
</dbReference>
<dbReference type="DrugBank" id="DB09462">
<property type="generic name" value="Glycerin"/>
</dbReference>
<dbReference type="DrugBank" id="DB11590">
<property type="generic name" value="Thimerosal"/>
</dbReference>
<dbReference type="TCDB" id="1.A.3.2.6">
<property type="family name" value="the ryanodine-inositol 1,4,5-triphosphate receptor ca(2+) channel (rir-cac) family"/>
</dbReference>
<dbReference type="GlyConnect" id="1399">
<property type="glycosylation" value="1 N-Linked glycan (1 site)"/>
</dbReference>
<dbReference type="GlyGen" id="Q14643">
<property type="glycosylation" value="1 site"/>
</dbReference>
<dbReference type="iPTMnet" id="Q14643"/>
<dbReference type="PhosphoSitePlus" id="Q14643"/>
<dbReference type="SwissPalm" id="Q14643"/>
<dbReference type="BioMuta" id="ITPR1"/>
<dbReference type="DMDM" id="519668682"/>
<dbReference type="EPD" id="Q14643"/>
<dbReference type="jPOST" id="Q14643"/>
<dbReference type="MassIVE" id="Q14643"/>
<dbReference type="MaxQB" id="Q14643"/>
<dbReference type="PaxDb" id="Q14643"/>
<dbReference type="PeptideAtlas" id="Q14643"/>
<dbReference type="PRIDE" id="Q14643"/>
<dbReference type="ProteomicsDB" id="17461"/>
<dbReference type="ProteomicsDB" id="60081">
<molecule id="Q14643-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="60082">
<molecule id="Q14643-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="60083">
<molecule id="Q14643-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="60084">
<molecule id="Q14643-4"/>
</dbReference>
<dbReference type="ProteomicsDB" id="60085">
<molecule id="Q14643-5"/>
</dbReference>
<dbReference type="ProteomicsDB" id="60086">
<molecule id="Q14643-6"/>
</dbReference>
<dbReference type="ProteomicsDB" id="60087">
<molecule id="Q14643-7"/>
</dbReference>
<dbReference type="ProteomicsDB" id="60088">
<molecule id="Q14643-8"/>
</dbReference>
<dbReference type="Antibodypedia" id="5503">
<property type="antibodies" value="382 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000302640">
<molecule id="Q14643-2"/>
<property type="protein sequence ID" value="ENSP00000306253"/>
<property type="gene ID" value="ENSG00000150995"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000357086">
<molecule id="Q14643-3"/>
<property type="protein sequence ID" value="ENSP00000349597"/>
<property type="gene ID" value="ENSG00000150995"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000443694">
<molecule id="Q14643-2"/>
<property type="protein sequence ID" value="ENSP00000401671"/>
<property type="gene ID" value="ENSG00000150995"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000456211">
<molecule id="Q14643-4"/>
<property type="protein sequence ID" value="ENSP00000397885"/>
<property type="gene ID" value="ENSG00000150995"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000648309">
<molecule id="Q14643-5"/>
<property type="protein sequence ID" value="ENSP00000497026"/>
<property type="gene ID" value="ENSG00000150995"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000649015">
<molecule id="Q14643-1"/>
<property type="protein sequence ID" value="ENSP00000497605"/>
<property type="gene ID" value="ENSG00000150995"/>
</dbReference>
<dbReference type="GeneID" id="3708"/>
<dbReference type="KEGG" id="hsa:3708"/>
<dbReference type="UCSC" id="uc003bqc.3">
<molecule id="Q14643-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3708"/>
<dbReference type="DisGeNET" id="3708"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000150995.18"/>
<dbReference type="GeneCards" id="ITPR1"/>
<dbReference type="GeneReviews" id="ITPR1"/>
<dbReference type="HGNC" id="HGNC:6180">
<property type="gene designation" value="ITPR1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000150995">
<property type="expression patterns" value="Tissue enhanced (parathyroid)"/>
</dbReference>
<dbReference type="MalaCards" id="ITPR1"/>
<dbReference type="MIM" id="117360">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="147265">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="206700">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="606658">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q14643"/>
<dbReference type="OpenTargets" id="ENSG00000150995"/>
<dbReference type="Orphanet" id="1065">
<property type="disease" value="Aniridia-cerebellar ataxia-intellectual disability syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="98769">
<property type="disease" value="Spinocerebellar ataxia type 15/16"/>
</dbReference>
<dbReference type="Orphanet" id="208513">
<property type="disease" value="Spinocerebellar ataxia type 29"/>
</dbReference>
<dbReference type="PharmGKB" id="PA29978"/>
<dbReference type="eggNOG" id="KOG3533">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000155071"/>
<dbReference type="HOGENOM" id="CLU_000206_1_0_1"/>
<dbReference type="InParanoid" id="Q14643"/>
<dbReference type="KO" id="K04958"/>
<dbReference type="OMA" id="MKLAHQF"/>
<dbReference type="OrthoDB" id="94996at2759"/>
<dbReference type="PhylomeDB" id="Q14643"/>
<dbReference type="TreeFam" id="TF312815"/>
<dbReference type="PathwayCommons" id="Q14643"/>
<dbReference type="Reactome" id="R-HSA-112043">
<property type="pathway name" value="PLC beta mediated events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-114508">
<property type="pathway name" value="Effects of PIP2 hydrolysis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-139853">
<property type="pathway name" value="Elevation of cytosolic Ca2+ levels"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1489509">
<property type="pathway name" value="DAG and IP3 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2029485">
<property type="pathway name" value="Role of phospholipids in phagocytosis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2871809">
<property type="pathway name" value="FCERI mediated Ca+2 mobilization"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-381676">
<property type="pathway name" value="Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4086398">
<property type="pathway name" value="Ca2+ pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-418457">
<property type="pathway name" value="cGMP effects"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-422356">
<property type="pathway name" value="Regulation of insulin secretion"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5218921">
<property type="pathway name" value="VEGFR2 mediated cell proliferation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5578775">
<property type="pathway name" value="Ion homeostasis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5607763">
<property type="pathway name" value="CLEC7A (Dectin-1) induces NFAT activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9664323">
<property type="pathway name" value="FCGR3A-mediated IL10 synthesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-983695">
<property type="pathway name" value="Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"/>
</dbReference>
<dbReference type="SignaLink" id="Q14643"/>
<dbReference type="SIGNOR" id="Q14643"/>
<dbReference type="BioGRID-ORCS" id="3708">
<property type="hits" value="2 hits in 873 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="ITPR1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="ITPR1"/>
<dbReference type="GenomeRNAi" id="3708"/>
<dbReference type="Pharos" id="Q14643">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:Q14643"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="RNAct" id="Q14643">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000150995">
<property type="expression patterns" value="Expressed in cauda epididymis and 238 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q14643">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q14643">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005955">
<property type="term" value="C:calcineurin complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030659">
<property type="term" value="C:cytoplasmic vesicle membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005783">
<property type="term" value="C:endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005789">
<property type="term" value="C:endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005637">
<property type="term" value="C:nuclear inner membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0031088">
<property type="term" value="C:platelet dense granule membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031094">
<property type="term" value="C:platelet dense tubular network"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031095">
<property type="term" value="C:platelet dense tubular network membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0014069">
<property type="term" value="C:postsynaptic density"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016529">
<property type="term" value="C:sarcoplasmic reticulum"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0030667">
<property type="term" value="C:secretory granule membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0030658">
<property type="term" value="C:transport vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0019855">
<property type="term" value="F:calcium channel inhibitor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005509">
<property type="term" value="F:calcium ion binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0015085">
<property type="term" value="F:calcium ion transmembrane transporter activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0015278">
<property type="term" value="F:calcium-release channel activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070679">
<property type="term" value="F:inositol 1,4,5 trisphosphate binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005220">
<property type="term" value="F:inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035091">
<property type="term" value="F:phosphatidylinositol binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006816">
<property type="term" value="P:calcium ion transport"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032469">
<property type="term" value="P:endoplasmic reticulum calcium ion homeostasis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042045">
<property type="term" value="P:epithelial fluid transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070059">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050849">
<property type="term" value="P:negative regulation of calcium-mediated signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0030168">
<property type="term" value="P:platelet activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0009791">
<property type="term" value="P:post-embryonic development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010506">
<property type="term" value="P:regulation of autophagy"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903779">
<property type="term" value="P:regulation of cardiac conduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0050796">
<property type="term" value="P:regulation of insulin secretion"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0099566">
<property type="term" value="P:regulation of postsynaptic cytosolic calcium ion concentration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0051209">
<property type="term" value="P:release of sequestered calcium ion into cytosol"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001666">
<property type="term" value="P:response to hypoxia"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050882">
<property type="term" value="P:voluntary musculoskeletal movement"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="InterPro" id="IPR016024">
<property type="entry name" value="ARM-type_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR014821">
<property type="entry name" value="Ins145_P3_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR000493">
<property type="entry name" value="InsP3_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR005821">
<property type="entry name" value="Ion_trans_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036300">
<property type="entry name" value="MIR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR016093">
<property type="entry name" value="MIR_motif"/>
</dbReference>
<dbReference type="InterPro" id="IPR013662">
<property type="entry name" value="RIH_assoc-dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000699">
<property type="entry name" value="RIH_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035910">
<property type="entry name" value="RyR/IP3R_RIH_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR45816">
<property type="entry name" value="PTHR45816"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF08709">
<property type="entry name" value="Ins145_P3_rec"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00520">
<property type="entry name" value="Ion_trans"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02815">
<property type="entry name" value="MIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF08454">
<property type="entry name" value="RIH_assoc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01365">
<property type="entry name" value="RYDR_ITPR"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PRINTS" id="PR00779">
<property type="entry name" value="INSP3RECEPTR"/>
</dbReference>
<dbReference type="SMART" id="SM00472">
<property type="entry name" value="MIR"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF100909">
<property type="entry name" value="SSF100909"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48371">
<property type="entry name" value="SSF48371"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF82109">
<property type="entry name" value="SSF82109"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50919">
<property type="entry name" value="MIR"/>
<property type="match status" value="5"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0106">Calcium</keyword>
<keyword id="KW-0107">Calcium channel</keyword>
<keyword id="KW-0109">Calcium transport</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0407">Ion channel</keyword>
<keyword id="KW-0406">Ion transport</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-1071">Ligand-gated ion channel</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0564">Palmitate</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0950">Spinocerebellar ataxia</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0813">Transport</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Inositol 1,4,5-trisphosphate receptor type 1" id="PRO_0000153920">
<location>
<begin position="1"/>
<end position="2758"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="10">
<location>
<begin position="1"/>
<end position="2282"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="10">
<location>
<begin position="2283"/>
<end position="2303"/>
</location>
</feature>
<feature type="topological domain" description="Lumenal" evidence="10">
<location>
<begin position="2304"/>
<end position="2314"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="10">
<location>
<begin position="2315"/>
<end position="2335"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="10">
<location>
<begin position="2336"/>
<end position="2361"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="10">
<location>
<begin position="2362"/>
<end position="2382"/>
</location>
</feature>
<feature type="topological domain" description="Lumenal" evidence="10">
<location>
<begin position="2383"/>
<end position="2405"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="10">
<location>
<begin position="2406"/>
<end position="2426"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="10">
<location>
<begin position="2427"/>
<end position="2448"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="10">
<location>
<begin position="2449"/>
<end position="2469"/>
</location>
</feature>
<feature type="topological domain" description="Lumenal" evidence="10">
<location>
<begin position="2470"/>
<end position="2577"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="10">
<location>
<begin position="2578"/>
<end position="2598"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="10">
<location>
<begin position="2599"/>
<end position="2758"/>
</location>
</feature>
<feature type="domain" description="MIR 1" evidence="11">
<location>
<begin position="112"/>
<end position="166"/>
</location>
</feature>
<feature type="domain" description="MIR 2" evidence="11">
<location>
<begin position="173"/>
<end position="223"/>
</location>
</feature>
<feature type="domain" description="MIR 3" evidence="11">
<location>
<begin position="231"/>
<end position="287"/>
</location>
</feature>
<feature type="domain" description="MIR 4" evidence="11">
<location>
<begin position="294"/>
<end position="373"/>
</location>
</feature>
<feature type="domain" description="MIR 5" evidence="11">
<location>
<begin position="379"/>
<end position="435"/>
</location>
</feature>
<feature type="region of interest" description="Inositol 1,4,5-trisphosphate binding" evidence="6">
<location>
<begin position="265"/>
<end position="269"/>
</location>
</feature>
<feature type="region of interest" description="Inositol 1,4,5-trisphosphate binding" evidence="6">
<location>
<begin position="508"/>
<end position="511"/>
</location>
</feature>
<feature type="region of interest" description="Inositol 1,4,5-trisphosphate binding" evidence="6">
<location>
<begin position="567"/>
<end position="569"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with ERP44" evidence="6">
<location>
<begin position="2472"/>
<end position="2537"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="10">
<location>
<position position="482"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1 2 3 4 5">
<location>
<position position="1598"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 4">
<location>
<position position="1764"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="10">
<location>
<position position="2664"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="S-palmitoyl cysteine" evidence="7">
<location>
<position position="56"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="S-palmitoyl cysteine" evidence="7">
<location>
<position position="850"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="19">
<location>
<position position="2512"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="8">
<location>
<position position="917"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="8">
<location>
<position position="972"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="8">
<location>
<position position="1581"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="8">
<location>
<position position="1780"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="8">
<location>
<position position="1893"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="8">
<location>
<position position="1894"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="8">
<location>
<position position="1895"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="8">
<location>
<position position="1910"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="8">
<location>
<position position="1933"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="8">
<location>
<position position="2127"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="8">
<location>
<position position="2266"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2, isoform 4, isoform 5, isoform 7 and isoform 8." id="VSP_002687" evidence="30 32 33">
<location>
<begin position="322"/>
<end position="336"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3, isoform 4, isoform 5 and isoform 8." id="VSP_002688" evidence="31 32 33">
<location>
<begin position="919"/>
<end position="927"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3 and isoform 4." id="VSP_002689" evidence="31 32 33">
<location>
<begin position="1702"/>
<end position="1724"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3, isoform 4, isoform 6, isoform 7 and isoform 8." id="VSP_002690" evidence="31 32 33">
<location>
<begin position="1725"/>
<end position="1740"/>
</location>
</feature>
<feature type="sequence variant" description="In SCA29; dbSNP:rs397514536." id="VAR_069567" evidence="21">
<original>N</original>
<variation>D</variation>
<location>
<position position="602"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35789999." id="VAR_037005">
<original>M</original>
<variation>V</variation>
<location>
<position position="769"/>
</location>
</feature>
<feature type="sequence variant" description="In SCA15; dbSNP:rs121912425." id="VAR_081167" evidence="18">
<original>P</original>
<variation>L</variation>
<location>
<position position="1083"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3749383." id="VAR_037006">
<original>I</original>
<variation>V</variation>
<location>
<position position="1430"/>
</location>
</feature>
<feature type="sequence variant" description="In SCA29; dbSNP:rs397514535." id="VAR_069569" evidence="21 24">
<original>V</original>
<variation>M</variation>
<location>
<position position="1562"/>
</location>
</feature>
<feature type="sequence variant" description="In GLSP." id="VAR_077462" evidence="26">
<original>E</original>
<variation>Q</variation>
<location>
<position position="2109"/>
</location>
</feature>
<feature type="sequence variant" description="In GLSP; dbSNP:rs752281590." id="VAR_077463" evidence="26">
<original>G</original>
<variation>R</variation>
<location>
<position position="2554"/>
</location>
</feature>
<feature type="sequence variant" description="In GLSP; dbSNP:rs878853176." id="VAR_077464" evidence="25">
<original>F</original>
<variation>L</variation>
<location>
<position position="2601"/>
</location>
</feature>
<feature type="sequence variant" description="In GLSP; alters calcium release of isoform 3." id="VAR_077465" evidence="25 26">
<location>
<position position="2611"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with AHCYL1." evidence="15">
<original>R</original>
<variation>Q</variation>
<location>
<position position="241"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with AHCYL1." evidence="15">
<original>K</original>
<variation>Q</variation>
<location>
<position position="249"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with AHCYL1." evidence="15">
<original>R</original>
<variation>Q</variation>
<location>
<position position="265"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with AHCYL1." evidence="15">
<original>T</original>
<variation>A</variation>
<location>
<position position="267"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with AHCYL1." evidence="15">
<original>R</original>
<variation>Q</variation>
<location>
<position position="269"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with AHCYL1." evidence="15">
<original>R</original>
<variation>Q</variation>
<location>
<position position="504"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with AHCYL1." evidence="15">
<original>R</original>
<variation>Q</variation>
<location>
<position position="506"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with AHCYL1." evidence="15">
<original>K</original>
<variation>A</variation>
<location>
<position position="508"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with AHCYL1." evidence="15">
<original>R</original>
<variation>A</variation>
<location>
<position position="511"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with AHCYL1." evidence="15">
<original>Y</original>
<variation>A</variation>
<location>
<position position="567"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with AHCYL1." evidence="15">
<original>R</original>
<variation>Q</variation>
<location>
<position position="568"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with AHCYL1." evidence="15">
<original>K</original>
<variation>A</variation>
<location>
<position position="569"/>
</location>
</feature>
<feature type="mutagenesis site" description="Creates a dileucine motif and recruits clathrin." evidence="28">
<original>P</original>
<variation>L</variation>
<location>
<position position="1059"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAD14386." ref="6" evidence="34">
<original>AIAIPVDLDSQVNNLFLKSHSIVQK</original>
<variation>HCHSRGPGQPSQQPLSQVPQHCAE</variation>
<location>
<begin position="1557"/>
<end position="1581"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB04947." ref="2" evidence="34">
<original>F</original>
<variation>L</variation>
<location>
<position position="2302"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB04947." ref="2" evidence="34">
<original>F</original>
<variation>L</variation>
<location>
<position position="2305"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; U23850." ref="4" evidence="34">
<original>S</original>
<variation>A</variation>
<location>
<position position="2448"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250"/>
<evidence key="7" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P11881"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P29994"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9TU34"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255"/>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00131"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12032348"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14685260"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15652484"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16793548"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16990611"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17590087"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18579805"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19159218"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19220705"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22986007"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23650607"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23884412"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26770814"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27108797"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27108798"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27995898"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30197081"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7852357"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7500840"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7852357"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7945203"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8648241"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000305"/>
<evidence key="35" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="27108798"/>
</source>
</evidence>
<sequence length="2758" mass="313929" checksum="D29B072252B0D8E7" modified="2013-06-26" version="3">MSDKMSSFLHIGDICSLYAEGSTNGFISTLGLVDDRCVVQPETGDLNNPPKKFRDCLFKLCPMNRYSAQKQFWKAAKPGANSTTDAVLLNKLHHAADLEKKQNETENRKLLGTVIQYGNVIQLLHLKSNKYLTVNKRLPALLEKNAMRVTLDEAGNEGSWFYIQPFYKLRSIGDSVVIGDKVVLNPVNAGQPLHASSHQLVDNPGCNEVNSVNCNTSWKIVLFMKWSDNKDDILKGGDVVRLFHAEQEKFLTCDEHRKKQHVFLRTTGRQSATSATSSKALWEVEVVQHDPCRGGAGYWNSLFRFKHLATGHYLAAEVDPDFEEECLEFQPSVDPDQDASRSRLRNAQEKMVYSLVSVPEGNDISSIFELDPTTLRGGDSLVPRNSYVRLRHLCTNTWVHSTNIPIDKEEEKPVMLKIGTSPVKEDKEAFAIVPVSPAEVRDLDFANDASKVLGSIAGKLEKGTITQNERRSVTKLLEDLVYFVTGGTNSGQDVLEVVFSKPNRERQKLMREQNILKQIFKLLQAPFTDCGDGPMLRLEELGDQRHAPFRHICRLCYRVLRHSQQDYRKNQEYIAKQFGFMQKQIGYDVLAEDTITALLHNNRKLLEKHITAAEIDTFVSLVRKNREPRFLDYLSDLCVSMNKSIPVTQELICKAVLNPTNADILIETKLVLSRFEFEGVSSTGENALEAGEDEEEVWLFWRDSNKEIRSKSVRELAQDAKEGQKEDRDVLSYYRYQLNLFARMCLDRQYLAINEISGQLDVDLILRCMSDENLPYDLRASFCRLMLHMHVDRDPQEQVTPVKYARLWSEIPSEIAIDDYDSSGASKDEIKERFAQTMEFVEEYLRDVVCQRFPFSDKEKNKLTFEVVNLARNLIYFGFYNFSDLLRLTKILLAILDCVHVTTIFPISKMAKGEENKGNNDVEKLKSSNVMRSIHGVGELMTQVVLRGGGFLPMTPMAAAPEGNVKQAEPEKEDIMVMDTKLKIIEILQFILNVRLDYRISCLLCIFKREFDESNSQTSETSSGNSSQEGPSNVPGALDFEHIEEQAEGIFGGSEENTPLDLDDHGGRTFLRVLLHLTMHDYPPLVSGALQLLFRHFSQRQEVLQAFKQVQLLVTSQDVDNYKQIKQDLDQLRSIVEKSELWVYKGQGPDETMDGASGENEHKKTEEGNNKPQKHESTSSYNYRVVKEILIRLSKLCVQESASVRKSRKQQQRLLRNMGAHAVVLELLQIPYEKAEDTKMQEIMRLAHEFLQNFCAGNQQNQALLHKHINLFLNPGILEAVTMQHIFMNNFQLCSEINERVVQHFVHCIETHGRNVQYIKFLQTIVKAEGKFIKKCQDMVMAELVNSGEDVLVFYNDRASFQTLIQMMRSERDRMDENSPLMYHIHLVELLAVCTEGKNVYTEIKCNSLLPLDDIVRVVTHEDCIPEVKIAYINFLNHCYVDTEVEMKEIYTSNHMWKLFENFLVDICRACNNTSDRKHADSILEKYVTEIVMSIVTTFFSSPFSDQSTTLQTRQPVFVQLLQGVFRVYHCNWLMPSQKASVESCIRVLSDVAKSRAIAIPVDLDSQVNNLFLKSHSIVQKTAMNWRLSARNAARRDSVLAASRDYRNIIERLQDIVSALEDRLRPLVQAELSVLVDVLHRPELLFPENTDARRKCESGGFICKLIKHTKQLLEENEEKLCIKVLQTLREMMTKDRGYGEKLISIDELDNAELPPAPDSENATEELEPSPPLRQLEDHKRGEALRQVLVNRYYGNVRPSGRRESLTSFGNGPLSAGGPGKPGGGGGGSGSSSMSRGEMSLAEVQCHLDKEGASNLVIDLIMNASSDRVFHESILLAIALLEGGNTTIQHSFFCRLTEDKKSEKFFKVFYDRMKVAQQEIKATVTVNTSDLGNKKKDDEVDRDAPSRKKAKEPTTQITEEVRDQLLEASAATRKAFTTFRREADPDDHYQPGEGTQATADKAKDDLEMSAVITIMQPILRFLQLLCENHNRDLQNFLRCQNNKTNYNLVCETLQFLDCICGSTTGGLGLLGLYINEKNVALINQTLESLTEYCQGPCHENQNCIATHESNGIDIITALILNDINPLGKKRMDLVLELKNNASKLLLAIMESRHDSENAERILYNMRPKELVEVIKKAYMQGEVEFEDGENGEDGAASPRNVGHNIYILAHQLARHNKELQSMLKPGGQVDGDEALEFYAKHTAQIEIVRLDRTMEQIVFPVPSICEFLTKESKLRIYYTTERDEQGSKINDFFLRSEDLFNEMNWQKKLRAQPVLYWCARNMSFWSSISFNLAVLMNLLVAFFYPFKGVRGGTLEPHWSGLLWTAMLISLAIVIALPKPHGIRALIASTILRLIFSVGLQPTLFLLGAFNVCNKIIFLMSFVGNCGTFTRGYRAMVLDVEFLYHLLYLVICAMGLFVHEFFYSLLLFDLVYREETLLNVIKSVTRNGRSIILTAVLALILVYLFSIVGYLFFKDDFILEVDRLPNETAVPETGESLASEFLFSDVCRVESGENCSSPAPREELVPAEETEQDKEHTCETLLMCIVTVLSHGLRSGGGVGDVLRKPSKEEPLFAARVIYDLLFFFMVIIIVLNLIFGVIIDTFADLRSEKQKKEEILKTTCFICGLERDKFDNKTVTFEEHIKEEHNMWHYLCFIVLVKVKDSTEYTGPESYVAEMIKERNLDWFPRMRAMSLVSSDSEGEQNELRNLQEKLESTMKLVTNLSGQLSELKDQMTEQRKQKQRIGLLGHPPHMNVNPQQPA</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

